8-K
Current Report
Damora Therapeutics, Inc. Filed Acc 0001193125-26-274093
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading dmra-20260428.htm…